Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-15

FDA Approved: CLIMARA PRO — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Climara Pro, a transdermal patch combining estradiol and levonorgestrel, from Bayer HealthCare Pharmaceuticals Inc. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLIMARA PRO (ESTRADIOL AND LEVONORGESTREL)

Snippet

SUPPL AP for CLIMARA PRO (ESTRADIOL AND LEVONORGESTREL)